BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16376828)

  • 1. Predicting protein druggability.
    Hajduk PJ; Huth JR; Tse C
    Drug Discov Today; 2005 Dec; 10(23-24):1675-82. PubMed ID: 16376828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive identification of "druggable" protein ligand binding sites.
    An J; Totrov M; Abagyan R
    Genome Inform; 2004; 15(2):31-41. PubMed ID: 15706489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational approaches to identifying and characterizing protein binding sites for ligand design.
    Henrich S; Salo-Ahen OM; Huang B; Rippmann FF; Cruciani G; Wade RC
    J Mol Recognit; 2010; 23(2):209-19. PubMed ID: 19746440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein-ligand interaction sites using experimental and computational methods.
    Vajda S; Guarnieri F
    Curr Opin Drug Discov Devel; 2006 May; 9(3):354-62. PubMed ID: 16729732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based maximal affinity model predicts small-molecule druggability.
    Cheng AC; Coleman RG; Smyth KT; Cao Q; Soulard P; Caffrey DR; Salzberg AC; Huang ES
    Nat Biotechnol; 2007 Jan; 25(1):71-5. PubMed ID: 17211405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New method for fast and accurate binding-site identification and analysis.
    Halgren T
    Chem Biol Drug Des; 2007 Feb; 69(2):146-8. PubMed ID: 17381729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DrugPred: a structure-based approach to predict protein druggability developed using an extensive nonredundant data set.
    Krasowski A; Muthas D; Sarkar A; Schmitt S; Brenk R
    J Chem Inf Model; 2011 Nov; 51(11):2829-42. PubMed ID: 21995295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification of proteins for selectivity assays.
    Yoon S; Smellie A; Hartsough D; Filikov A
    Proteins; 2005 May; 59(3):434-43. PubMed ID: 15770646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based identification of small molecule binding sites using a free energy model.
    Coleman RG; Salzberg AC; Cheng AC
    J Chem Inf Model; 2006; 46(6):2631-7. PubMed ID: 17125203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the druggable concavity in homology models using the PLB index.
    Soga S; Shirai H; Kobori M; Hirayama N
    J Chem Inf Model; 2007; 47(6):2287-92. PubMed ID: 17935312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Druggability of human disease genes.
    Sakharkar MK; Sakharkar KR; Pervaiz S
    Int J Biochem Cell Biol; 2007; 39(6):1156-64. PubMed ID: 17446117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Druggability indices for protein targets derived from NMR-based screening data.
    Hajduk PJ; Huth JR; Fesik SW
    J Med Chem; 2005 Apr; 48(7):2518-25. PubMed ID: 15801841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus scoring for protein-ligand interactions.
    Feher M
    Drug Discov Today; 2006 May; 11(9-10):421-8. PubMed ID: 16635804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and characterizing binding sites and assessing druggability.
    Halgren TA
    J Chem Inf Model; 2009 Feb; 49(2):377-89. PubMed ID: 19434839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based computational analysis of protein binding sites for function and druggability prediction.
    Nisius B; Sha F; Gohlke H
    J Biotechnol; 2012 Jun; 159(3):123-34. PubMed ID: 22197384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.